Reuters: Health
GlaxoSmithKline and AstraZeneca will each present trial data on a promising new class of drugs against ovarian cancer on Saturday as Britain's top drugmakers compete to burnish their oncology credentials.
GSK, AstraZeneca rivalry takes center stage at cancer conference
GSK, AstraZeneca rivalry takes center stage at cancer conference
Reuters: Health
GlaxoSmithKline and AstraZeneca will each present trial data on a promising new class of drugs against ovarian cancer on Saturday as Britain's top drugmakers compete to burnish their oncology credentials.
Reuters: Health
GlaxoSmithKline and AstraZeneca will each present trial data on a promising new class of drugs against ovarian cancer on Saturday as Britain's top drugmakers compete to burnish their oncology credentials.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment